Applications of molecular testing in surgical pathology of the head and neck

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Modern Pathology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/modpathol.2016.192PMID 28060367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance

  2016cited by this paper
• A Policy Framework for Health Systems to Promote Triple Aim Innovation.

  2016cited by this paper
• Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics—Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer

  2016cited by this paper
• Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.

  2016cited by this paper
• Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma

  2016cited by this paper
• Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma

  2016cited by this paper
• Precision Oncology Medicine: The Clinical Relevance of Patient‐Specific Biomarkers Used to Optimize Cancer Treatment

  2016cited by this paper
• Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.

  2016cited by this paper
• MYB-fusions and other potential actionable targets in adenoid cystic carcinoma

  2016cited by this paper
• Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas

  2016cited by this paper
• Point-Counterpoint: The FDA Has a Role in Regulation of Laboratory-Developed Tests

  2016cited by this paper
• The importance of predictive biomarkers in oncology drug development

  2016cited by this paper
• Considerations for Implementation of Cancer Molecular Diagnostics Into Clinical Care.

  2016cited by this paper
• Origin of cystic squamous cell carcinoma metastases in head and neck lymph nodes: Addition of EBV testing improves diagnostic accuracy.

  2016cited by this paper
• A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics

  2016cited by this paper
• Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma

  2016cited by this paper
• Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.

  2016cited by this paper
• Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus

  2016cited by this paper
• Determining the Public/Private Mix: Options for Financing Targeted Universality in Long-Term Care.

  2016cited by this paper
• Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma

  2016cited by this paper
• Genomic and Epigenomic Alterations in Cancer.

  2016cited by this paper
• Shifting Away From Fee-For-Service: Alternative Approaches to Payment in Gastroenterology.

  2016cited by this paper
• Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer

  2016cited by this paper
• Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention.

  2016cited by this paper
• Single-cell sequencing in cancer research

  2016cited by this paper
• Is treatment de-escalation a reality in HPV related oropharyngeal cancer?

  2016cited by this paper
• FDA regulation of laboratory-developed tests.

  2016cited by this paper
• Companion diagnostic assays for PD-1/PD-L1 checkpoint inhibitors in NSCLC

  2016cited by this paper
• Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.

  2016cited by this paper
• Taking Triple Aim at the Triple Aim.

  2016cited by this paper
• Adenosquamous carcinoma of the head and neck: Molecular analysis using CRTC‐MAML FISH and survival comparison with paired conventional squamous cell carcinoma

  2015cited by this paper
• Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling

  2015cited by this paper
• Clear Cell Myoepithelial Carcinoma of Salivary Glands Showing EWSR1 Rearrangement: Molecular Analysis of 94 Salivary Gland Carcinomas With Prominent Clear Cell Component

  2015cited by this paper
• Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.

  2015cited by this paper
• DNA Repair and Chromosomal Translocations.

  2015cited by this paper
• Warthin-like Mucoepidermoid Carcinoma: A Combined Study of Fluorescence In Situ Hybridization and Whole-slide Imaging

  2015cited by this paper
• De-escalation of radiation dose for human papillomavirus-positive oropharyngeal head and neck squamous cell carcinoma: A case report and preclinical and clinical literature review

  2015cited by this paper
• Salivary Gland Cancers: Biology and Systemic Therapy.

  2015cited by this paper
• Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology.

  2015cited by this paper
• Adamantinoma-like Ewing Family Tumors of the Head and Neck: A Pitfall in the Differential Diagnosis of Basaloid and Myoepithelial Carcinomas

  2015cited by this paper
• Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies.

  2015cited by this paper
• Advancements in the Management of HPV-Associated Head and Neck Squamous Cell Carcinoma

  2015cited by this paper
• Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.

  2015cited by this paper
• Disruptive Innovation in Academic Medical Centers: Balancing Accountable and Academic Care

  2015cited by this paper
• Molecular Testing in Anatomic Pathology and Adherence to Guidelines: A College of American Pathologists Q-Probes Study of 2230 Testing Events Reported by 26 Institutions.

  2015cited by this paper
• Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials

  2015cited by this paper
• What Accountable Care Organizations Can Learn from Kaiser Permanente California's Acute Care Strategy

  2015cited by this paper
• Adenoid cystic carcinoma of the head and neck--An update.

  2015cited by this paper
• Improving Molecular Genetic Test Utilization through Order Restriction, Test Review, and Guidance.

  2015cited by this paper
• The Affordable Care Act: A Primer for Plastic Surgeons

  2014cited by this paper
• Epstein-Barr Virus and Human Papillomavirus Infections and Genotype Distribution in Head and Neck Cancers

  2014cited by this paper
• Treatment outcomes of sinonasal adenoid cystic carcinoma: 30 cases from a single institution.

  2014cited by this paper
• Sequencing the head and neck cancer genome: implications for therapy

  2014cited by this paper
• Management structure: establishing a laboratory utilization program and tools for utilization management.

  2014cited by this paper
• The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.

  2014cited by this paper
• The Patient Protection and Affordable Care Act: opportunities for prevention and public health.

  2014cited by this paper
• Laboratory test interpretations and algorithms in utilization management.

  2014cited by this paper
• Metastatic renal cell carcinoma, clear cell type, of the parotid gland

  2014cited by this paper
• Human Papillomavirus–related Carcinoma With Adenoid Cystic–like Features: A Peculiar Variant of Head and Neck Cancer Restricted to the Sinonasal Tract

  2013cited by this paper
• Salivary gland cancer: an update on present and emerging therapies.

  2013cited by this paper
• Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations

  2013cited by this paper
• CRTC1-MAML2 and CRTC3-MAML2 Fusions Were Not Detected in Metaplastic Warthin Tumor and Metaplastic Pleomorphic Adenoma of Salivary Glands

  2013cited by this paper
• Translocation-associated Salivary Gland Tumors: A Review and Update

  2013cited by this paper
• WITHDRAWN: Laboratory Test Interpretations and Algorithms in Utilization Management

  2013cited by this paper
• Fusion Oncogenes in Salivary Gland Tumors: Molecular and Clinical Consequences

  2013cited by this paper
• What the EWSR1-ATF1 Fusion has Taught Us About Hyalinizing Clear Cell Carcinoma

  2013cited by this paper
• MAML2 rearrangement in Warthin's tumour: a fluorescent in situ hybridisation study of metaplastic variants.

  2012cited by this paper
• Reappraisal of KIT mutation in adenoid cystic carcinomas of the salivary gland.

  2012cited by this paper
• A Cytohistologic Correlation of Mucoepidermoid Carcinoma: Emphasizing the Rare Oncocytic Variant

  2011cited by this paper
• Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing

  2011cited by this paper
• Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.

  2011cited by this paper
• Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: A review

  2011cited by this paper
• Health care reform in 2010: transforming the delivery system to improve quality of care

  2011cited by this paper
• Undifferentiated carcinoma of the oropharynx: a human papillomavirus-associated tumor with a favorable prognosis

  2011cited by this paper
• Clear Cell Carcinoma and Clear Cell Odontogenic Carcinoma: a Comparative Clinicopathologic and Immunohistochemical Study

  2011cited by this paper
• EWSR1‐ATF1 fusion is a novel and consistent finding in hyalinizing clear‐cell carcinoma of salivary gland

  2011cited by this paper
• c-kit gene mutations in adenoid cystic carcinoma are rare

  2010cited by this paper
• POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands

  2008cited by this paper
• Detection of a t(1;22)(q23;q12) translocation leading to an EWSR1‐PBX1 fusion gene in a myoepithelioma

  2008cited by this paper
• The triple aim: care, health, and cost.

  2008cited by this paper
• A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands.

  2007cited by this paper
• Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies.

  2007cited by this paper
• Mapping the cancer genome

  2007cited by this paper
• Cancer genome sequencing: the challenges ahead.

  2007cited by this paper
• The cancer genome atlas: new weapon in old war?

  2006cited by this paper
• Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate

  2005cited by this paper
• Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA‐FISH

  2001cited by this paper
• Translocation (11;19)(q21;p13.1) in mucoepidermoid carcinoma of salivary gland.

  1995cited by this paper
• Translocation(11;19)(q14-21;p12) in a parotid mucoepidermoid carcinoma of a child.

  1995cited by this paper
• Recurrent rearrangements of 11q14-22 in mucoepidermoid carcinoma.

  1994cited by this paper
• Molecular Diagnostics: Past, present, and future

  1993cited by this paper
• Molecular biology in the diagnosis and prognosis of solid and lymphoid tumors.

  1992cited by this paper
• Chromosome rearrangement, oncogene activation, and other clonal events in cancer: Their use in molecular diagnostics

  1991cited by this paper
• Effect of diagnosis-related groups on diagnostic methodology in the hospital laboratory.

  1986cited by this paper
• Alternative Units of Payment for Physician Services : An Overview of the Issues

  1986cited by this paper

• Fast Metabolic Glycan Labeling for Click-Labeling and Imaging of Sialoglycans in Living Acute Brain Slices from Mice and Human Patients.

  2024cites this paper
• Molecular Neuropathology versus Histopathology in the Diagnosis of Central Nervous System Tumors: Review Article about Novel Diagnostic and Investigative Technologies

  2022cites this paper
• Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Journal of Pathology Informatics

  year unknowncites this paper